http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-2022007317-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16f4f652bb4ac0b15a38fc937aa49142
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
filingDate 2022-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caeb93d598bd10ca9bd81f6522bf95f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe65e3ec3eabd53197eac6b117d92fc
publicationDate 2022-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-2022007317-A2
titleOfInvention New chemical compound of l-lysine 9-oxoacridinyl-10-acetate
abstract The invention relates to chemistry, pharmacy and medicine, and in particular to a new chemical compound from the class of 9-oxoacridinyl-10-acetate derivatives: L-lysine 9-oxoacridinyl-10-acetate, which stimulates the production of interleukin-24 (IL-24) and tumor necrosis factor beta (TNF-β), in addition to having antitumor activity. The invention can be used for antitumor therapy, in particular as an adjuvant in the combined treatment of oncological diseases. The objective of the invention is to create a new chemical compound that stimulates the production of the cytokines interleukin-24 and tumor necrosis factor beta, and has antitumor activity with low toxicity. The problem is solved by a new chemical compound: L-lysine 9-oxo-acridinyl-10-acetate, represented by formula (I) or (II).
priorityDate 2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554305
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10154
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5TM20
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485577
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280845
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25008
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09225
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9JM09
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11009
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61125
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID607183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407742
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26445
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ13007
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06332
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XT48
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID526285
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9JI24
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ925S4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID93672
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5WR07
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16992

Total number of triples: 42.